Despite incredible therapeutic innovations, the process for manufacturing these life-changing drugs lagged behind.
Because of the largely paper-based processes involved in pharma manufacturing, millions of dollars were lost in drug batches due to quality deviations. These legacy processes just weren’t going to hold up to the demands of new therapies – biologics, cell, and gene.
We created Apprentice to bring the pharma industry up to speed with the transformative potential of technology.
By bringing together co-founder Angelo Stracquatanio from the world of tech with fellow co-founders Gary Pignata and Alexandra Buttke from pharma, we’re developing expeditious ways to create medicines that will forever make life better for the people who need them most – patients.
We're proud of the ways our products, solutions, services — and people — are being seen and celebrated in the world of life science.
We’re building a company for the future led by innovators from high-growth tech and pharma.
We’re backed on this journey by leading investors in tech and healthcare. Together, we’re invested in helping the industry transform.